The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out moreCreate an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View pso content recommended for you
Diagnosis of psoriasis is often based on clinical features, rather than histological examination. The use of tools such as body surface area (BSA), Physician’s Global Assessment, and the Psoriasis Area and Severity Index can help clinicians categorize the severity of psoriasis. However, these tools do not account for disease impact in special areas, such as the face, scalp, and genitals.
Here, we summarize a study by Horner et al.1 in Dermatology and Therapy, which described BSA distribution, special area involvement, and available treatments, to evaluate disease burden in a real-world setting.
Figure 1. A Several special areas are involved, and B prevalence of special areas by body location*
*Adapted from Horner, et al.1
Key learnings |
|
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content